Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

59.3K
Overview
59.3K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

876
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
876
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

209
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
209
Antimicrobial Proteins01:23

Antimicrobial Proteins

12.9K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.9K
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

191
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
191
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Small-molecule IGF1R inhibitors extend healthspan in a mouse model.

bioRxiv : the preprint server for biology·2026
Same author

Identification of Compound <b>15</b> (MMV1581361) as a <i>Pf</i>ATP4 Inhibitor with Transmission-Blocking Activity and <i>In Vivo</i> Efficacy in a SCID Mouse Model of Malaria.

Journal of medicinal chemistry·2026
Same author

A Novel Class of Orally Bioavailable Phenylglycine-Benzoxaborole Conjugates with Antimalarial Activity and Potentially Novel Mechanism of Action.

ACS medicinal chemistry letters·2026
Same author

Optimization of 2,8-Diaryl-1,5-naphthyridines as <i>Plasmodium falciparum</i> Phosphatidylinositol 4-Kinase Inhibitors with Improved ADME Profiles and In Vivo Efficacy.

Journal of medicinal chemistry·2025
Same author

Cell-Based Progression of Spiroindoline Phenotypic Hits Leads to the Identification of Compounds with Diverging Parasitological Profiles against the Human Malaria Parasite <i>Plasmodium falciparum</i>.

Journal of medicinal chemistry·2025
Same author

Design of Novel Mercapto-3-phenylpropanoyl Dipeptides as Dual Angiotensin-Converting Enzyme C-Domain-Selective/Neprilysin Inhibitors.

Journal of medicinal chemistry·2025

Related Experiment Video

Updated: Jan 7, 2026

Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
11:00

Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress

Published on: August 31, 2015

8.7K

Negamycin: Nature's Forgotten Antibiotic.

Grant A Boyle1, Gregory S Basarab1

  • 1Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town, Cape Town 7701, South Africa.

ACS Infectious Diseases
|December 26, 2025
PubMed
Summary

Negamycin, an antibiotic effective against Gram-negative bacteria, offers a novel approach to combatting infections due to its unique ribosome inhibition mechanism. Research explores its analogs for enhanced potency and clinical development.

Keywords:
antibacterialsnegamycinpharmacokineticsprotein biosynthesis inhibitionribosomestructure-activity relationshiptotal synthesis

More Related Videos

The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms
05:57

The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms

Published on: July 2, 2013

13.7K
Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining
08:04

Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining

Published on: February 8, 2019

9.0K

Related Experiment Videos

Last Updated: Jan 7, 2026

Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
11:00

Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress

Published on: August 31, 2015

8.7K
The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms
05:57

The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms

Published on: July 2, 2013

13.7K
Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining
08:04

Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining

Published on: February 8, 2019

9.0K

Area of Science:

  • Natural Product Antibiotics
  • Medicinal Chemistry
  • Molecular Biology

Background:

  • Negamycin, discovered in 1970, is a natural product antibiotic with Gram-negative activity.
  • Its structural simplicity and novel ribosome inhibition mechanism make it a valuable starting point for drug discovery.
  • It exhibits no cross-resistance with existing antibacterial agents, addressing a critical medical need.

Purpose of the Study:

  • To review the published literature on negamycin and its analogs.
  • To explore their biological spectrum of activity and mode of action.
  • To identify limitations hindering clinical development.

Main Methods:

  • Survey of over 20 total syntheses of negamycin and its analogs.
  • Structural elucidation of negamycin's binding to the 30S ribosome A-site.
  • Investigation into the mechanism of negamycin transport into bacterial cytoplasm.

Main Results:

  • Development of synthetic methodologies enabling the creation of novel analogs.
  • Identification of more potent analogs than the parent compound.
  • Understanding of negamycin's interaction with the ribosome-tRNA complex.

Conclusions:

  • Negamycin and its analogs represent a promising avenue for addressing Gram-negative bacterial infections.
  • Further research into synthetic analogs and clinical development is warranted.
  • Overcoming current limitations is key to realizing the therapeutic potential of negamycin.